Loading...
•
Dec 31, 2025
Beta Bionics Inc Q4 2025 Earnings Report
Beta Bionics Inc reported its financial results for the fourth quarter and full year ended December 31, 2025, and introduced its annual guidance for the year ending December 31, 2026.
Key Takeaways
Beta Bionics Inc. demonstrated strong growth in Q4 2025, with net sales increasing by 57% to $32.1 million, driven by significant expansion in the Pharmacy Benefit Plan channel. The company also saw a substantial increase in its installed customer base and new patient starts, while improving its gross margin.
Net sales for Q4 2025 reached $32.1 million, a 57% increase compared to $20.4 million in Q4 2024.
The Pharmacy Benefit Plan (PBP) channel experienced remarkable growth, with net sales up 295% to $9.8 million in Q4 2025.
The installed customer base grew by 129% to 35,011 users in Q4 2025, reflecting strong patient adoption.
Gross margin improved to 59.0% in Q4 2025, up 179 basis points from 57.2% in Q4 2024.
Revenue by Segment
Forward Guidance
Beta Bionics, Inc. provided full year 2026 guidance, anticipating total revenue between $130 million and $135 million, with 36% to 38% of new patient starts reimbursed through the PBP channel, and a gross margin of 55.5% to 57.5%.
Positive Outlook
- Estimated total revenue for 2026 is projected to be between $130 million and $135 million, indicating continued growth.
- A significant portion of new patient starts, estimated at 36% to 38%, is expected to be reimbursed through the PBP channel, reflecting expanding market access.
- Gross margin is projected to be strong, ranging from 55.5% to 57.5%, suggesting continued profitability.
- The company expects to initiate an additional Phase 2a feasibility trial in H1 2026 for its bihormonal system, advancing its R&D pipeline.
- Progression to Phase 2b is anticipated after the Phase 2a trial, which is a pivotal trial-enabling, more robust feasibility trial.
Challenges Ahead
- No specific negative forward guidance points were explicitly stated in the provided text.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...